Skip to content

Clinical trials

Phase 2 Lymphatic Metastasis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphatic Metastasis Phase: Phase 2 Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20121
20182
20191
20213
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting1
Recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cancer Institute and Hospital, Chinese Academy of Medical Sciences2
M.D. Anderson Cancer Center2
ECOG-ACRIN Cancer Research Group1
Mayo Clinic1
University Medical Center Groningen1
University of Leeds1
University of Utah1
Universitätsklinikum Köln1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphatic Metastasis10
Carcinoma, Hepatocellular2
Prostatic Neoplasms2
Colonic Neoplasms1
Hypopharyngeal Neoplasms1
Laryngeal Neoplasms1
Melanoma1
Mouth Neoplasms1
Oropharyngeal Neoplasms1
Paranasal Sinus Neoplasms1

Trials

Showing 26 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.